Francis Ndungu/Lancet Infect Dis

Determinants of antibody persistence across doses and continents after single-dose rVSV-ZEBOV vaccination for Ebola virus disease: an observational cohort study.Huttner, A. Agnandji, S. T. Combescure, C. Fernandes, J. F. Bache, E. B. Kabwende, L. Ndungu, F. M. Brosnahan, J. Monath, T. P. Lemaitre, B. Grillet, S. Botto, M. Engler, O. Portmann, J. Siegrist, D. Bejon, P. Silvera, P. Kremsner, P. Siegrist, C. A. Vebcon, Vsv, Ebovac Vsv-Eboplus Consortia
Lancet Infect Dis, (2018). 18:738-748